FDA Warning Letter — Daewoo Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Daewoo Pharmaceutical Co., Ltd. on Jun 26, 2025 (Saha, South Korea). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Daewoo Pharmaceutical Co., Ltd.
- Date
- Jun 26, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Center
- CDER
- Location
- Saha (South Korea)